 |
Clinical Studies
For those of you interested in learning more about Survanta and surfactant, here is a list of clinical studies that provide additional information.
Survanta Studies
Hoekstra RE, Jackson JC, Myers TF, et al: Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.
Pediatrics 1991;88:10-18.
Horbar JD, Soll RF, Schachinger H, et al: A European multicenter randomized controlled trial
of single dose surfactant therapy for idiopathic respiratory distress syndrome.
Eur J Pediatr 1990;149:416-423.
Liechty EA, Donovan E, Purohit D, et al: Reduction of neonatal mortality after multiple doses
of bovine surfactant in low birth weight neonates with respiratory distress syndrome.
Pediatrics 1991;88:19-28.
Soll RF, Hoekstra RE, Fangman JJ, et al: Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome.
Pediatrics 1990;85:1092-1102.
Survanta Multidose Study Group: Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant.
J Pediatr 1994;124:962-967.
Whitsett JA, Hull WM, Luse S: Failure to detect surfactant protein-specific antibodies in sera
of premature infants treated with Survanta, a modified bovine surfactant.
Pediatrics 1991;87:505-510.
Zola EM, Gunkel JH, Chan RK, et al: Comparison of three dosing procedures for administration
of bovine surfactant to neonates with respiratory distress syndrome.
J Pediatr 1993;122:453-459.
Zola EM, Overbach AM, Gunkel JH, et al: Treatment investigational new drug experience with Survanta (beractant).
Pediatrics 1993;91:546-551.
Additional Studies
Bloom BT, Kattwinkel J, Hall RT, et al: Comparison of Infasurf (calf lung surfactant extract)
to Survanta (beractant) in the treatment and prevention of respiratory distress syndrome.
Pediatrics 1997;100:31-38.
Horbar JD, Wright LL, Soll RF, et al: A multicenter randomized trial comparing two surfactants
for the treatment of neonatal respiratory distress syndrome.
J Pediatr 1993;123:757-766.
Letters to the Editor: On "A Randomized, Multicenter Masked Comparison Trial of Poractant
Alfa (Curosurf) versus Beractant (Survanta) in the Treatment of Respiratory Distress Syndrome
in Preterm Infants"
(Am J Perinatol 2004;21:109-120)
Ramanathan R, Rasmussen M, Gerstmann D, et al: A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
Am J Perinatol 2004;21:109-119.
Vermont-Oxford Neonatal Network: A multicenter, randomized trial comparing synthetic
surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory
distress syndrome.
Pediatrics 1996;97:1-6.
* IMS DDD Lung Surfactant Market Purchases July 1991 through June 2007. On file, Abbott Nutrition Marketing Research.
|
|
